Diagnostic value of NKG2D promoter methylation in hepatitis B virus-associated hepatocellular carcinoma.
Conclusion: NKG2D promoter methylation can be used as a noninvasive marker for detecting HCC.
PMID: 31411040 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research
More News: Cancer & Oncology | Carcinoma | Genetics | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Internal Medicine | Liver Cancer